February 8, 2025 - 00:54

A collaborative research team from POSTECH has made significant strides in the field of gastric cancer treatment by developing a cutting-edge model utilizing 3D bioprinting technology combined with patient-derived cancer tissue fragments. This groundbreaking model not only replicates the complex architecture of gastric tumors but also maintains the unique characteristics of the individual patient's cancer cells.
The innovative approach allows researchers to better understand the tumor microenvironment and the interactions between cancer cells and surrounding tissues. By closely mimicking real-life conditions, this 3D bioprinted model serves as an invaluable tool for testing various therapeutic strategies, ultimately leading to more personalized treatment options for patients suffering from gastric cancer.
As the research progresses, the potential for this technology to revolutionize cancer treatment becomes increasingly apparent. By enabling the development of tailored therapies, this advancement could significantly enhance the effectiveness of treatments and improve patient outcomes in the battle against gastric cancer.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...